Xu, Enquan
Boddu, Ravindra
Abdelmotilib, Hisham A.
Sokratian, Arpine
Kelly, Kaela
Liu, Zhiyong
Bryant, Nicole
Chandra, Sidhanth
Carlisle, Samantha M.
Lefkowitz, Elliot J.
Harms, Ashley S.
Benveniste, Etty N.
Yacoubian, Talene A.
Volpicelli-Daley, Laura A.
Standaert, David G.
West, Andrew B. http://orcid.org/0000-0002-3034-4061
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (P50NS108675, R01NS064934)
Article History
Received: 27 May 2021
Accepted: 14 December 2021
First Online: 10 January 2022
Declarations
:
: All study protocols were approved by local Institutional Review Boards and Institutional Animal Care and Use Committees.
: A.B.W. is a member of the Scientific Advisory Board for the Michael J. Fox Foundation and an active consultant for eScapeBio, Inc., and Neuro23, Inc., and has received research support unrelated to this study from Biogen/Idec. R.B. has no competing interests. K.K. has no competing interests. S.C. has no competing interests. S.M.C. has no competing interests. A.S. had no competing interests. D.G.S. is a member of the faculty of the University of Alabama at Birmingham and is supported by endowment and University funds. Dr. Standaert is an investigator in studies funded by Abbvie, Inc., the American Parkinson Disease Association, the Michael J. Fox Foundation for Parkinson Research, Alabama Department of Commerce, the Department of Defense, and NIH grants P50NS108675, R25NS079188, and T32NS095775. He has a clinical practice and is compensated for these activities through the University of Alabama Health Services Foundation. In addition, since January 1, 2020 he has served as a consultant for or received honoraria from Abbvie Inc., Sutter Health, the International Parkinson Disease and Movement Disorder Society, Theravance, McGraw Hill, Curium Pharma, F. Hoffmann - LaRoche, Grey Matter Technologies and Sanofi-Aventis. E.N.B. is a member of the faculty of the University of Alabama at Birmingham and is supported by endowment and University funds. E.N.B. is an investigator in studies funded by the Michael J. Fox Foundation for Parkinson Research, the National Multiple Sclerosis Society, the Department of Defense, and NIH grants R01-NS5756, R01-CA194414, P50-NS108675, R01NS1-9529, R01-CA246708, and R01-AI148711. E.N.B is also a consultant for or received honoraria from the SONTAG Brain Tumor Foundation, The Race to Erase MS Foundation, the NIH, the American Association for Medical Colleges, Young Investigators Forum in Neuro-Oncology, Shanghai Jiantong University, and the Univ. of California at San Francisco.